SEC Form 4Coverage since Jul 30, 2026
$PTIX insider trading
Over the last 12 months, Protagenic Therapeutics, Inc.\new insiders reported 2 buys totaling $6K and no sales across SEC Form 4 filings.
- Bought · 12m
- $6K 2 events
- Sold · 12m
- — 0 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $PTIX · 12Mvia TradingView
Top insiders · 12m
ARMEN GARO HEXEC. CHAIR & PRINCIPAL OFF.1× · $5K
ARMEN GARO HEXEC. CHAIR & PRINCIPAL OFF1× · $1K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | ARMEN GARO HEXEC. CHAIR & PRINCIPAL OFF · O·D | ▲ Buy | 5,000 | $0.26 | $1K | +19% | — |
| Jul 30, 2026 | ARMEN GARO HEXEC. CHAIR & PRINCIPAL OFF. · O·D | ▲ Buy | 26,291 | $0.18 | $5K | — | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $PTIX feed.